2015 Annual Meeting | Clinical Trials Plenary Session
| 12:00 PM - 12:15 PM |
Amifampridine Phosphate (FirdapseTM) is safe and Effective in a Pivotal Phase 3 Trial in LEMS Patients
Shin J. Oh, MD, FAAN |
|
| 12:15 PM - 12:30 PM |
Effect of MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of a Pivotal Phase III Randomized Double Blind Placebo Controlled Study
Ayman P. Tourbah |
|
| 12:30 PM - 12:45 PM |
Idebenone Reduces Loss of Respiratory Function in Duchenne Muscular Dystrophy - Outcome of a Phase III Double Blind, Randomised, Placebo-controlled Trial (DELOS)
Gunnar Buyse, MD, PhD |
|
| 12:45 PM - 01:00 PM |
The Multicenter Randomized Clinical trial of endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN): Update and Clinical Implications
Diederik W. Dippel, MD |
|
| 01:00 PM - 01:15 PM |
Phenytoin is Neuroprotective in Acute Optic Neuritis: Results of a Phase 2 Randomized Controlled Trial
Raju Kapoor, MD |
|
| 01:15 PM - 01:30 PM |
Panel Discussion
|
| Gunnar Buyse, MD, PhD | No disclosure on file |
| Raju Kapoor, MD | No disclosure on file |
| Shin J. Oh, MD, FAAN | No disclosure on file |
| Ayman P. Tourbah | No disclosure on file |
| Diederik W. Dippel, MD | No disclosure on file |